Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Yield10 Bioscience Inc YTEN

Healthcare Biotechnology
Yield10 Bioscience, Inc. is an agricultural bioscience company that is leveraging advanced genetics to develop the oilseed Camelina sativa (Camelina) as a platform crop for large-scale production of sustainable seed products. These seed products include feedstock oils for renewable diesel and sustainable aviation biofuels; omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical and... see more

Recent & Breaking News (OTCQB:YTEN)

Yield10 Bioscience Announces Fourth Quarter and Full Year 2021 Financial Results

GlobeNewswire March 9, 2022

Yield10 Bioscience Announces Recent Advances in the Development of Camelina as a Production Platform for PHA Bioplastic

GlobeNewswire March 8, 2022

Yield10 Bioscience Announces an Update on the Camelina Line E3902 Development Program for Producing Low-carbon Feedstock Oil for Renewable Diesel

GlobeNewswire March 3, 2022

Yield10 Bioscience to Announce Fourth Quarter and Full Year 2021 Financial Results and Host a Conference Call on Wednesday, March 9, 2022

GlobeNewswire March 2, 2022

Yield10 Bioscience Field Test Results Show Seed Oil Content Increase in Camelina and Canola

GlobeNewswire March 1, 2022

Yield10 Bioscience Receives Favorable Ruling from the Argentine Biosafety Commission (CONABIA) for Company's Camelina Lines

GlobeNewswire February 2, 2022

Yield10 Bioscience Hires Darren Greenfield as Senior Director of Seed Operations

GlobeNewswire January 25, 2022

Yield10 Bioscience to Present at the H.C. Wainwright Bioconnect Virtual Conference

GlobeNewswire January 4, 2022

Yield10 Bioscience to Participate in the Benzinga Global Small Cap Conference on December 9, 2021

GlobeNewswire December 6, 2021

Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advances in Utilizing CRISPR Genome Editing to Increase Seed Oil Content in Camelina at Canola Week Conference

GlobeNewswire December 2, 2021

Yield10 Bioscience Announces Third Quarter 2021 Financial Results

GlobeNewswire November 10, 2021

Yield10 Bioscience to Announce Third Quarter 2021 Financial Results and Host a Conference Call on Wednesday, November 10, 2021

GlobeNewswire November 3, 2021

Yield10 Bioscience to Participate in Maxim Group AgTech Virtual Conference

GlobeNewswire October 7, 2021

Yield10 Bioscience to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

GlobeNewswire September 9, 2021

Yield10 Bioscience Announces Second Quarter 2021 Financial Results

GlobeNewswire August 11, 2021

Yield10 Bioscience to Announce Second Quarter 2021 Financial Results and Host a Conference Call on Wednesday, August 11, 2021

GlobeNewswire August 3, 2021

Yield10 Bioscience Begins 2021 Field Test and Seed Scale Up Program

GlobeNewswire July 13, 2021

Yield10 Bioscience Announces Two New Hires as Camelina Business Plan Advances

GlobeNewswire June 29, 2021

Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advances Using Camelina Platform to Produce PHA Bioplastic at 2021 Synthetic Biology: Engineering, Evolution and Design Virtual Conference

GlobeNewswire June 16, 2021

Yield10 Bioscience to Present at the LD Virtual Invitational XI on June 9, 2021

GlobeNewswire May 27, 2021